Professor Arduino A Mangoni trained in Cardiology, Clinical Pharmacology and General Medicine in Milan, Boston and London. He was awarded a PhD in Pharmacology at King’s College, University of London, in 2003. He was appointed Senior Lecturer (2003-2007) and Associate Professor (2007-2009) in Clinical Pharmacology at Flinders University before taking up the Chair in Medicine of Old Age at the University of Aberdeen, UK (2010-2012). In 2013 he was appointed Strategic Professor of Clinical Pharmacology and Head of Department at Flinders University. In 2015, he became Associate Dean and Head, Flinders Medical Science and Technology. He plays a key role in the regular review of the Australian Hypertension guidelines and has contributed to the development of the SIGN guidelines on the Management of Chronic Pain, released in December 2013. His research interest include metabolomics and ageing, drug discovery and geriatric clinical pharmacology. Professor Mangoni has published over 140 refereed publications. Arduino Mangoni is a clinical academic, Professor and Head of the Department of Clinical Pharmacology and Associate Dean and Head, Flinders Medical Science and Technology, in the School of Medicine at Flinders University in Adelaide.
Dr. Joris is an internist by training and holds a UK board certification in clinical pharmacology & therapeutics. He initially joined the UK Medicines Control Agency (now MHRA) and was subsequently involved in the clinical development of neurology and psychiatry products at major pharmaceutical companies, first in European Regulatory Affairs and Drug Safety, and latterly in Global Clinical Development. During his time in the industry, he worked on the development of molecules throughout its life cycle, including the first-in-human studies, not only in neuroscience but also in other therapeutic areas, such as cardiometabolic disorders.
Dr. Eid obtained his Ph.D. in Biomedical Sciences from the Ohio State University where he conducted his doctoral (and later postdoctoral) research at the Davis Heart and Lung Research Institute. He had previously obtained his MSc from Bowling Green State University, USA, and his BSc from the American University of Beirut. His main research focus in the laboratory is the molecular and cellular pharmacology that culminates in drug discovery. He is also involved in teaching Medical students and graduate and undergraduate level courses and has garnered several teaching awards.
Dr. Duconge is a full professor of pharmacokinetics and pharmacogenomics in the University of Puerto Rico School of Pharmacy. He received his Ph.D. in Pharmaceutical Sciences, MSc and BSc Pharm from the University of Havana. He led the Pharmacokinetics Lab, Center for Biological Evaluation and Research, Havana. He has 18+ years of experience in scholarly activities and research projects on pharmacokinetics and pharmacodynamics of biotech-derived drug products, and more recently, working on the pharmacogenomics of cardiovascular drugs. His research has been supported by multiple NIH grants. He is the Key Activity Leader of the RCMI Center for Genomics in Health Disparities and Rare Diseases. Dr. Duconge has authored more than 75 research articles, reviews and book chapters.
Dr. Sachin Kumar Singh is a Pharmaceutical Analyst and holds his Masters of Pharmacy in Pharmaceutical Analysis from J.S.S. College of Pharmacy, Ooty, Tamilnadu, India and Ph.D degree in Pharmaceutical Sciences from Karpagam University, Coimbatore, India. As Associate Professor, School of Pharmaceutical Sciences, Lovely Professional University. He has completed one DST-SERB funded project on development of SNEDDS of polypeptide-k for treatment of diabetes mellitus. He has published more than 60 papers; co-authored 4 books; applied for 3 patents. He is the recipient of 2014 Bharat Shiksha Ratan Award given by Global Society for Health and Educational Growth, Delhi, India.
Adriana Georgescu, PhD. Habil, is the Principal Investigator Grade I, Biophysicist, Head of Department of Pathophysiology and Pharmacology, Institute of Cellular Biology and Pathology ‘Nicolae Simionescu’, Bucharest, Romania. Her studies are focused on the cellular and molecular mechanisms underlying pathophysiological and physiological processes in the cardiovascular system, to define new therapeutic approaches for atherosclerosis regression and prevention of cardiovascular disease events. The current research interests involve: microparticles as intracellular delivery strategies for microRNAs and potential therapies for atherosclerotic vascular disease; endothelial progenitor cell dysfunction and plateletendothelial progenitor cell interplay in atherosclerotic disease.
Dr. Elnour has received his PhD in School of Pharmacy, Queen’s University Belfast, N. Ireland-United Kingdom during the period of 2000-2004. Currently, he is working as Associate Professor of Pharmacy Practice, College of Pharmacy at Gulf Medical University. He also served as a researcher and research supervisor for assisting the PhD and MSc postgraduate students at several universities (25 Master students and 2 PhD students). He was honored as Editor of Medicine (Baltimore), Editorial board in many Journals and Regional editor. He is also serving as a reviewer in American Journal of Pharmaceutical Education-AJPE since 2008. He is former associate professor of Clinical Pharmacy, and Pharmacy Program Lead at Fatima College of Health Sciences, Al Ain-UAE and former adjunct Clinical associate professor in Pharmacology Department at United Arab Emirates University-UAEU. He has authored 100 research articles, Meta- analysis and Editorial Letters. He is a member of several professional and therapeutics committees like UAE University Ethics and Research Committee.
Dr. Sayeed Ahmad has been associated in teaching and research since 2005. He has been honored with many awards, postdoc from Albert Einstien College of Medicine New York, with > 240 publications and author of book “Introduction to Pharmacognosy”. He has been associated with more than 30 sponsored research projects from different funding agencies in addition to industry based consultancy projects. He has supervised 28 M Pharm and 23 PhD scholars. His field of interest in research are Metabolomics, Chromatographic analysis including HPTLC, HPLC and GCMS etc for targeted and untargeted metabolites in biological systems and for quality control.
Dr. Ajith T.A., born on 30 March 1972, received his Master of Science in Medical Biochemistry from Kasturba Medical College, Mangalore, India in 1996 securing FIRST RANK and Ph. D in Medical Biochemistry from Research Centre, AIMS, Kerala, India. He has been PROFESSOR in Biochemistry at Amala Institute of Medical Sciences, Kerala, India, since July, 2012. He has authored 85 articles in peer-reviewed National and International journals. He has edited/authored 2 books and contributed 10 chapters. Currently, he is co-principal investigator of 2 funded research projects. He is the NABH lab assessor for Minimum essential standards and NABL internal auditor.
Karel Allegaert (MD, PhD) is a pediatrician-neonatologist, with an additional expertise in clinical pharmacology. He is professor at the KU Leuven (department of development and regeneration) and is clinical consultant at the Sophia’s Children’s Hospital, Rotterdam, the Netherlands. His research is focused on developmental perinatal pharmacology, has been supported by European funding (Albino study), and national grants (FWO, IWT-SBO) and has resulted in about 280 PubMed citations. He is member of the Royal Academy of Medicine of Belgium, president of the European Society of Developmental Pharmacology and section head clinical pharmacology of the European Society of Pediatric Research.
Marco Atteritano obtained medical degree in the year 2000 and in 2005 and specialization with distinction in the Internal Medicine at the University of Messina. In 2010, he obtained PhD in Specialistic Medicine at the University of Messina. He was Assistant Professor of Rheumatology at the University of Messina. Currently, he is a research fellow at the University of Messina in the Internal Medicine-Rheumatology and coordinator of project of research funded by the Italian Ministry of Health. He won several awards in the rheumatology field and internal medicine field. He is the author of 50 peer-reviewed papers. His main fields of interest are the Rank-Rankl-OPG system in bone disease.
Professor Michel Bourin was a Professor of Pharmacology at the University of Nantes (1985 to 2011). After completing his pharmacist and medical training at Tours University, he was awarded degrees in neuropsychopharmacology, clinical pharmacology and general pharmacology in Paris, and he then completed his psychiatric training in Nantes. Since 1988, Professor Bourin has been the Head of Research: Neurobiology of Anxiety and Depression. He has also served as an Adjunct Professor in the Department of Psychiatry at the University of Edmonton and visiting professor at the University of Craiova. He is now working as a psychiatrist in the centre for mentally handicapped adults in Montredon. He is Doctor Honoris Causa of the Universities of Craiova and Tartu.
Prof. Francesco Paolo Busardò obtained his Degree with honor in Medicine and Surgery at theUniversity of Palermo (Italy), winning the Prize for the Best Thesis; he also got a MSc in Forensic Toxicology at the University of Glasgow (Scotland) and a PhD in Forensic Science at “Sapienza” University of Rome (Italy), where he currently works as researcher in forensic toxicology. He is author of more than 100 papers with I.F., with a total I.F. higher than 290 and h-index of 13.
Professor Ufuk Çakatay has been working as a senior scientist at Department of Medical Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University. Dr. Çakatay was formerly working as an associate professor at Central Laboratory of Clinical Biochemistry, Istanbul Faculty of MedicineHis research interests include: optimization of bioanalytic methods for measurement oxidative stress, experimental animal models of aging and age-related disorders. He has had a long-term interest in various protein oxidation biomarkers such as protein carbonyl groups, protein hydroperoxides, advanced oxidation protein products, and nitrotyrosine.
Prof. Dr. Omar Cauli got the Specialization in Pharmacology (University of Cagliari, Italy), He is a full professor at University of Valencia (Spain) in Department of Nursing. He took his PhD in Neurosciences and he has published more the 90 articles in prestigious international journals. He is author and reviewer of several scientific articles in internationally recognized journals related to different disciplines of Health Sciences. He has participated in the organization of various symposia, workshops and seminars in the field of his research lines.
Prof Balram is Clinical Pharmacologist at National Cancer Center Singapore (NCCS). As one of the leading researchers in pharmacogenomics in Singapore, his research focuses on understanding pharmacogenomics influences on the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs especially in Asian ethnic groups. He is also the Director of SingHealth Clinical Pharmacology core platform which offers therapeutic drug monitoring, bioanalytical, pharmacokinetics and genotyping services to local healthcare institutions, pharmaceutical companies and academic research laboratories. He has co-authored over 90 publications and is also an editorial board member for numerous drug metabolism and pharmacology-based journals. Prof Balram holds multiple academic appointments at Duke-NUS Graduate Medical School and Nanyang Technological University, Singapore (NTU) and currently serves on advisory committees, grant review boards and research councils at national level.
Dr. Randhir Singh is presently serving as a Professor at M M college of Pharmacy Maharishi Markandeshwar University, Mullana. He completed his B.Pharmacy from Guru Jambhashwar University, Hisar in 2002 and he further completed his M. Pharmacy from Baharti Vidhyapeeth Deemed University, Pune. In 2011, he got PhD degree from Punjabi University Patiala. He has been recognized with Saroj V.N- Sharma Award. He has contributed his publications in different journals.
Prof. Giuseppe Derosa, MD, PhD, FESC was born in Lodi (Italy) and has accomplished his Medical Doctor Degree at the Faculty of Medicine of the University of Milan, San Raffaele Hospital, Italy. He has achieved the Specialization in Internal Medicine at the University of Pavia, Italy, and the PhD (Doctorate of Medical Pathophysiology and Therapy) at the University of Pavia, Italy. He is Assistant Professor of Internal Medicine at the Department of Internal Medicine and Therapeutics, University of Pavia, Italy, and he is currently Aggregate Professor at the University of Pavia, Italy, and Chief of Diabetes and Metabolic Diseases Centre at the Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy. He is the author of 249 original articles, published in international journals with IF (888,643), 50 reviews, 29 chapters, and 6 monographs in the field of diabetes, lipid disorders, obesity and hypertension.
D. Douroumis’s research area is on the development of secondary continuous manufacturing by using hot melt extrusion (HME) of extrusion granulation coupled with PAT tools. His group is also involved in the development of targeted anticancer drug delivery systems, such as SLNs or NLCs produced by high-pressure homogenization. He is actively involved in ink jetting and 3D printing technologies for the development of medical devices (e.g. microneedles, stents) and personalized medicines.
Prof. Ali A. Ensafi was graduated in Chemistry (Ph.D.) in 1991 in Analytical Chemistry from Shiraz University (Iran). He became full professor in 2001 at Isfahan University of Technology. He is head of the Center of Excellence in Sensors & Green Chemistry of Ministry of Sciences, Research & Technology of Iran. He has an H-index of 54. He has published more than 420 ISI papers, and he has more than 150 international and/or national oral presentation. He has awarded three international awards. He is co-author of four books, and he is also associate editor of the Journal the Iranian Chemical Society.
Dr. Gian Luca Erre, MD, PhD, was born in Sassari and has accomplished his Medical Doctor Degree at the Faculty of Medicine of the University of Sassari (Italy) in 1999. He was awarded a PhD in pathophysiology of rheumatic diseases at University of Sassari in 2008. He is Senior Consultant at the Azienda Ospedaliero-Universitaria of Sassari. His research interest include the pathogenesis of rheumatic disease, atherosclerosis and endothelial dysfunction in rheumatic diseases and the cardiovascular effect of immunosuppressive and antiinflammatory drugs. Dr. Erre has authored more than 50 research articles including reviews and book chapter in the field of rheumatic diseases.
Dr. Ahmed Fawzy El-Yazbi did PhD in Pharmacology from University of Alberta, Edmonton, Alberta in 2008. Currently he is an Assistant Professor of Pharmacology and Toxicology at the American University of Beirut. He is also an Adjunct Assistant-Professor of Pharmacology and Toxicology at the Alexandria University, Alexandria, Egypt. Dr. El-Yazbi has a very extensive teaching profile that includes skill development and evaluation. He taught at Faculties of Pharmacy, Medicine and Dentistry in Alexandria University, University of Alberta, University of Calgary, Beirut Arab University, and the American University of Beirut.
Francesco Fiorica MD, PhD accomplished his Medical Doctor Degree at the Faculty of Medicine in the University of Palermo. He achieved the Specialization in Radiation Oncology from the University of Modena, Italy, and the PhD (Doctorate of Geriatric Oncology Management) from the University of Catania, Italy. He is a senior consultant at the University Hospital of Ferrara and Responsible of Section of Radiation Oncology Day Hospital and High Specialized. He is the author of more than 100 original articles, published in the international journals: His total citations are 1569 (scopus), 2243 (google scholar); and his h-index is 16 (Scopus).
Dr. Fromm studied medicine at the Friedrich-Alexander-University Erlangen-Nürnberg (Germany). He worked as a post doctoral fellow at the Dr. Margarete-Fischer-Bosch Institute of Clinical Pharmacology, (Stuttgart, Germany) and at the Division of Clinical Pharmacology of Vanderbilt University (Nashville, TN, USA). Since 2004, Dr. Fromm is Professor of Clinical Pharmacology and Clinical Toxicology (Chair) at the Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University Erlangen-Nürnberg. Dr. Fromm is author of more than 180 publications (h index 55) and is a Highly Cited Researcher 2015 in the field “Pharmacology & Toxicology” (Thomson Reuters).
Dr. Galigniana is a Biochemist at the University of Buenos Aires (UBA), P.I. of the CONICET scientific career of Argentina, and professor of the UBA. He is the director of the Laboratory of Nuclear Receptors of the Institute for Experimental Biology & Medicine (IBYME), and the Laboratory of Molecular & Cellular Biology of the UBA. His research is focused on the study of heat-shock proteins and Hsp90-binding immunophilins in the regulation of cell division, cell death and cancer development. He has conducted studies on the subcellular trafficking of steroid receptors, HSF1, NF-kB and AP1, and neuronal differentiation and neuroregeneration.
Dr. Di Girolamo obtained a Medical degree in the School of Medicine from Universidad de Buenos Aires in 1980. PhD in Pharmacology in 1984 and MD in Clinical Pharmacology in 2000 from Universidad de Buenos Aires. Dr. Di Girolamo is Adjunct Professor in Pharmacology in the Department of Pharmacology and Toxicology at School of Medicine from Universidad de Buenos Aires. He is Director of Center for Monitoring and Safety of Drugs and Director of Cardiological Research Institute "Prof Dr Alberto C. Taquinini" School of Medicine from Universidad de Buenos Aires. His research interest includes clinical pharmacokinetic, pharmacovigilance, and cardiovascular clinical pharmacology. He has published more than 70 scientific refereed publications.
Prof. Dr. Claudio Guarneri, MD, studied from the University of Messina, Italy, School of Medicine and Surgery - Degree in Medicine and Surgery. In 1999, he became Specialist in Dermatology and Venereology from University of Messina, Messina, Italy. In 2003, he did Master in Dermatologic Surgery from University of Siena, Italy in 2005. He worked as Medical Director Dermatologist at the ‘Pugliese-Ciaccio’ Regional Hospital, Catanzaro, Italy from 2005 to 2006. He is currently working as Assistant Professor of Dermatology and Venereology at the Department of Clinical Experimental Medicine, Institute of Dermatology, University of Messina, Messina, Italy since 2006.
Dr. Deepali Gupta received training in Neuroendocrinology and Behavioral Sciences. She was awarded a PhD in Neuropsychopharmacology at Birla Institute of Technology and Sciences, Pilani, India in 2016. She was appointed Assistant Instructor (2021) and Instructor (2022) in the Center for Hypothalamic Research at UT Southwestern Medical Center, Dallas Texas after completing five years of postdoctoral fellowship there under Dr. Jeffrey Zigman. Her research interests include diabetes and obesity, behavioral disorders, endocrinology and neuropharmacology.
Hossein Hassanian-Moghaddam, MD, FACMT, has been a clinical toxicologist for almost 20 years, in a University affiliated hospital in Tehran. Loghman-Hakim Hospital Poison Center is the main referral hospital for poisoned patients in Tehran and is managed by Shahid Beheshti University of Medical Sciences. Between 24000 and 27000 intoxicated patients refer to this center annually, of whom approximately 10000–12000 are hospitalized. Loghman hospital supposed to be the biggest in-patient clinical toxicology center of the world. His educational background in forensic medicine and working in this unique hospital has given him a broad base to deal with a number of social issues such as substance abuse and poisoning are his every-day practice, which are reflected in more than 200 published English abstracts and articles in scientific journals and international congresses.
Esmaiel Jabbari is Full Professor of Chemical and Biomedical Engineering and Director of Biomaterials, Protein Delivery, and Tissue Engineering at University of South Carolina. He completed his PhD at Purdue University and postdoctoral studies at Monsanto, Rice University, and Mayo Clinic. He is internationally known for his work on the synthesis of nanogels for spatiotemporally controlled delivery of proteins in regenerative medicine. He received the Berton Rahn Award from AO Foundation in 2012 and the Stephen Milam Award from OMSF in 2008. He was elected to the College of Fellows of AIMBE in 2013. He has published>230 scientific articles, presented >260 seminars, and mentored >130 scholars.
Dr. Kuladip Jana, M.Sc., M.S., Ph.D. is presently serving as a Senior Scientist in the Division of Molecular Medicine and Scientist In-charge of the Centre for Translational Animal Research, Bose Institute, Kolkata, India. Dr. Jana was trained as a Post-doctoral Research Associate at Garrison Institute on Aging, Texas Tech University Health Sciences Centre, Texas, U.S.A. and in National Institute of Cholera & Enteric Diseases, Kolkata and also served as a Visiting Scientist at Saha Institute of Nuclear Physics, Kolkata after obtaining his M.S. and Ph.D. in Reproductive Medicine from an Indian University.
Dr. Kim is a professor at College of Pharmacy, Seoul National University. He has nearly 30 years of experience in the research, discovery and development of medications aimed to treat liver diseases. Previously, Dr. Kim holds Ph.D., in Department of Pharmacology, Northwestern University Medical School. Notably, Dr. Kim has authored more than 250 manuscripts, more than 20 patents. Dr. Kim is now a member of ASBMB and ASPET in U.S.A., and editorial board members of Journal of Molecular Signaling, Current Patents on Anti-Cancer Drug Discovery, Current Clinical Pharmacology, World Journal of Gastrointestinal Pathophysiology and World Journal of Gastroenterology.
Dr. Igor Kissin is a professor at the Department of Anesthesia, Brigham and Women’s Hospital, Harvard Medical School, USA. He completed his PhD in pharmacology from the Institute for Pharmacology and Chemotherapy, Moscow, USSR in 1959, after which joined the institute as a junior scientist and later continued to work as a senior scientist until 1965. He also worked as a professor of anesthesiology at School of Medicine, University of Alabama at Birmingham from 978-1993. He serves as an editorial board member for various reputed journals and has also won many academic and professional awards. His research interests include cardiovascular pharmacology, general anesthetic action, local anesthesia, opioid pharmacology, postoperative analgesia, treatment of chronic pain, pharmacology of vanilloid agonists, and assessment of medical research using specific publication-based indices and has made various publications in international reputed journals.
Birgit C.P. Koch is an Associate Professor in Clinical Pharmacology. She studied pharmacy at the University of Utrecht in the Netherlands. Her master research was performed at the Royal North Shore Hospital in Sydney. In 2003, she became a Pharmacist. From October 2011, she is Hospital Pharmacist-Clinical Pharmacologist and Head of the Pharmacy Laboratory of Erasmus MC, focusing on Therapeutic Drug monitoring, Toxicology and Quality Control of pharmaceutical products. She supervises the education program for residents in Clinical Pharmacology. Her research focuses on alternative matrices, chronopharmacology, pharmacokinetics and pharmacodynamics of drugs in special populations and toxicology during pregnancy.
Dr Krishna’s work focuses on the Clinical Pharmacology (CP), and Quantitative CP (QCP) to create & optimize CP program strategies, efficient clinical trial with decision making end points (PK, PD, safety, efficacy, biomarker) for all phases of drug development to (a) identify covariates to optimize dose selection, (b) generate a robust ECD/CP profile of a compound & prescribing information, and (c) differentiate and maximize product value as a part of Life Cycle Management. Dr. Krishna has more than 140 manuscripts/abstracts/presentations/book chapter and is peer reviewers for and editorial board member of the Journals, and co-inventor on several patents.
Dirk Kuypers is Professor of Medicine and Chair of the Laboratory of Nephrology, Department of Microbiology and Immunology, at the University of Leuven, Belgium. He is Head of the Department of Nephrology and Director of the Renal Transplantation Program at the University Hospitals Leuven. His clinical and translational research is focused on (personalized) immunosuppressive therapy and renal allograft surveillance using protocol biopsies and (bio)markers of allograft status. Professor Kuypers has published more than 260 papers on nephrology, clinical pharmacology and transplantation (h-index 45) and has authored several book chapters.
Professor Lang is a consultant cardiologist and clinical pharmacologist and Professor of Cardiology at University of Dundee. He graduated MbChB from the University of Dundee in 1985 and trained in both cardiology and clinical pharmacology in the UK and in the USA, where he was a Merck Fellow at Vanderbilt University, Nashville, and a Fulbright Scholar at Columbia University, New York. His patient-oriented research takes a multidisciplinary approach to the understanding of the pathophysiology of heart failure and cardio-metabolic diseases. He has published more than 200 papers in peer-reviewed journals and has an h-index of 43.
Sebastiano Leone, MD, is an infectious diseases specialist at “San Giuseppe Moscati” Hospital, Avellino, Italy. He previously served as IDS at “Riuniti” Hospital, Bergamo, Italy, and at “San Gerardo” Hospital, Monza, Italy. He also previously served as researcher and assistant professor at University of Salerno, Italy. Dr Leone’s clinical and research interests include epidemiology and outcomes of antimicrobial resistance, adequate and rational use of antimicrobials, management of severe community- and hospital-acquired infections, management of HIV and viral hepatitis and coinfected patients. He has served as a reviewer for several international infectious diseases scientific journals.
Dr. Min Li is Professor of Medicine, Surgery, and Cell Biology, and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Director of GI Cancer Research, Department of Medicine, and Vice Chair for Research, Department of Surgery, at The University of Oklahoma Health Sciences Center. He is a leading expert on pancreatic cancer. His research mainly focuses on studying pancreatic cancer (PC) pathogenesis and developing new therapies. Dr. Li’s group has published more than 140 papers, and obtained both federal (3 active NIH R01 grants) and private foundation grants to support his research. He is also a member of many NIH study sections.
Cristina Maccallini received her Summa cum Laude degree in Chemistry and Pharmaceutical Technology in 1998, and in 2002 she obtained her Ph.D. in Drug Sciences. She is assistant professor of medicinal chemistry at the Pharmacy Department of the "G. d'Annunzio" University of Chieti. Her main research interests cover the development of new ligands of receptors and enzymes involved in the development of the metabolic syndrome, cancer and inflammation. She is author of 48 peer reviewed articles and 1 chapter in a book.
She is teacher of “Pharmaceutical Analysis II” at the Pharmacy Department of the "G. d'Annunzio" University of Chieti.
Dr. Alberto Marra completed his study in Medicine from the “Federico II” School of Medicine in Naples (Italy) in 2008. Then, in 2009, he started his Internal Medicine training at the “Federico II” University Hospital of Naples. In 2014, Dr. Marra received the Internal Medicine Specialist degree, and in 2015, he came to the "Thoraxclinic at Heidelberg University Hospital" and started his Ph.D. on hormonal abnormalities in pulmonary hypertension and right ventricle failure. In 2017, Dr. Marra was elected Secretary of the European Young Internists (YIs) and in the same year was appointed as Chairman of the Internal Medicine Assessment of Gender differences in Europe (IMAGINE) of the European Federation of Internal Medicine (EFIM).
Stuart graduated from the University of Leeds with First Class Honors in Pharmacology and was awarded the Pfizer Prize for undergraduate research. After gaining his Ph.D. in Receptor Pharmacology, he was then awarded a Howard Hughes Medical Institute Fellowship Award to train with Professor Robert Lefkowitz at Duke University. Following this fellowship Stuart was recruited to be Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) at the University of Edinburgh. Stuart then accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health.
Dr. Mansouri graduated as Doctor of Pharmacy from Ahvaz Jundishapur University of Medical Sciences (AJUMS), Iran and as Ph.D. in Pharmacology from Mashhad University of Medical Sciences (MUMS), Iran. He is currently working as an assistant professor in AJUMS; so far he has published more than 50 peer-reviewed manuscripts in international scientific journals, trained 10 Ph.D. students and more than 15 undergraduates under his supervision. Dr. Mansouri is an active academic scientist with an overall research focus on behavioral neuroscience and neuropharmacology in animal models of neurodegenerative diseases, such as Alzheimer’s, Parkinson’s diseases, vascular dementia, animal models of pain, anxiety, tolerance & dependence on drugs, and also inflammation.
Dr Nikhat Manzoor is Associate Professor of Medical Mycology at College of Applied Medical Sciences, Taibah University, Al Madinah Al Munawarah, KSA since 2014. She is a faculty member in Department of Biosciences, Jamia Millia Islamia, New Delhi, India since 2006 teaching Biophysics, Human Physiology and Toxicology and conducting research in Antimicrobial drug discovery and development. She received her PhD from the same university in 1999 and postdoctoral experience at School of Dentistry, University of Otago, New Zealand. She has published more than 80 refereed papers, delivered invited talks, completed major research projects, supervised PhDs and post-doctoral students.
Omid Mehrpour (MD, FACMT) is a medical toxicologist. He is an associate professor at the University affiliated hospital in Birjand, Iran. He has been associated with teaching and research since 2009. He has international collaboration with Rocky Mountain Poison and Drug Center, Denver, USA. He has been associated with more than 50 sponsored research projects from different funding agencies. He also received many national and international awards for his research. He is a member of the Iranian Academy of Medical Sciences. His research is focused on medical toxicology especially in substance abuse and pharmaceutical poisoning and metal poisoning. His research produced about 150 articles in scientific journals and international congresses. He has been a reviewer for more than 30 international journals.
Dr. Mehvar holds PharmD and PhD degrees in Pharmacy and Pharmaceutical Sciences, respectively, and is a Professor and Chair of the Department of Biomedical and Pharmaceutical Sciences at Chapman University School of Pharmacy in Irvine, California. He has been a faculty member in US Schools of Pharmacy since 1988, teaching courses and conducting research in the areas of pharmacokinetics, pharmacodynamics, drug metabolism, and drug delivery. Dr. Mehvar has received several awards for both his teaching and research accomplishments, including Texas Tech University Health Sciences Center President’s Excellence in Research Award and Texas Tech University System Chancellor’s Council Distinguished Teaching Award.
Dr. Muntean is an assistant professor of Microbiology at the University of Medicine and Pharmacy "Victor Babes" Timisoara, Romania. She received her Ph.D. in Medical Sciences from the University of Timisoara. She works in the Clinical Lab, Emergency Clinical County Hospital “Pius Branzeu” Timisoara. She has 14 years of experience in scholarly activities and research projects on antimicrobial resistance and hospital acquired infections, and more recently, working on the antimicrobial activity of essential oils or other plant extracts. Her research has been supported by three medical grants. Dr. Muntean has authored more than 60 research articles, reviews or book chapters.
Dr. Jagriti Narang, working as an assistant professor in Amity Institute of nanotechnology-Amity University, Noida, India. Her contributions in research are: 60 research papers with total impact of 160.0; Inventor, Patentee (7 Indian Patents) on biosensors and uses of nanotechnology in molecular techniques. Dr. Narang is working on the development of nano-enabled interfaces coupled with smart molecules for electrochemical sensing of various metabolites. She has developed a device for the detection of rape that takes place due to the influence of hypnotic drugs spiked in alcohol drinks in order to reduce the rape crime. She is recipient of various travel awards and was also awarded silver medal for extraordinary contribution during PhD. Grantee. She is committee member of many international conferences. She is also the member of MRSI, Society of biological chemistry, Materials Today etc. She has attended many international conferences and presented papers.
Dr. Joseph Fomusi Ndisang is an Associate Professor in the University of Saskatchewan College of Medicine, Department of Physiology. He received postdoctoral training in Physiology at the University of Saskatchewan College of Medicine from 2000-2005. He obtained a PhD in Pharmacology & Toxicology from the University of Florence, Italy, 2000. He obtained a Doctor of Pharmacy degree from University of Florence, Italy in 1995. He has received several distinguished awards and distinctions including: (i) Fellow of the Canadian Cardiovascular Society, (ii) Fellow of the American Heart Association (FAHA) in 2011; (iii) Fellow of the International College of Angiology.
Adina Popa is an associate professor of Clinical Pharmacy at the University of Medicine and Pharmacy ”Iuliu Hatieganu” Cluj-Napoca, Faculty of Pharmacy, where she has been a faculty member since 1994. She is head of the Clinical Pharmacy department. She completed her PhD from the same university in 2001. Her main area of interest and research is the optimization of the pharmacotherapy and the role of the pharmacist. She has published articles and books as author or co-author on the evaluation of patterns of drug use in various populations and health care settings, the development of instruments aiming for drug use optimization, and the assessment of clinical relevance of drug interactions. She has been involved in clinical studies planning including protocol, investigator brochure and informed consent development, case report form design, institutional ethical committee submission, and study monitoring.
Dr. Nikolaos Papanas is Associate Professor in Internal Medicine-Diabetes Mellitus at Democritus University of Thrace, Greece. He has been specialized in diabetes and its complications in the Diabetes Center and the Diabetic Foot Clinic at King’s College Hospital, London, UK, as well as in the German Diabetes Center at the Heinrich Heine University, Düsseldorf, Germany. He has established an ongoing collaboration with the neuropathy study group of the German Diabetes Center in Düsseldorf. He has published more than 255 papers in peer-reviewed journals with more than 3200 citations. He serves in the editorial board of more than 60 international journals.
Georgios Papazisis MD, PhD, is Assistant Professor of Clinical Pharmacology. He is a practicing psychiatrist specialized in psychopharmacology. He currently serves as an External Expert and Clinical Assessor for the European Medicines Agency and for the Pharmacovigilance Department of the Greek National Organization for Medicines. Dr. Papazisis is the Treasurer of the Greek Society of Pharmacology and Clinical Pharmacology and is member of the ‘Evidence Based Psychiatry’ section of the World Psychiatric Association. Dr Papazisis is an ad-hoc reviewer of several international journals and has published 33 Pub-Med papers, 55 indexed abstracts and 2 international book chapters.
Dr. Jalal Pourahmad graduated as Doctor of Pharmacy in 1988 From Mashhad University, Iran and as PhD in Toxicology in 2001 from University of Toronto, Canada. He is currently working as a Full Professor in Shahid Beheshti University of Medical Sciences, Tehran, Iran. He has so far published three academic books, 2 book chapters and more than 118 scientific papers in English and Farsi.
Dr. Kanwal Rehman is currently working as an Assistant Professor at Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan. She obtained her PhD in Pharmacology and Toxicology from Zhejiang University, Hangzhou, China. Dr. Kanwal’s individual research contribution internationally is quite noteworthy and acknowledged. The impact of her work is significant in the field of pharmaceutical sciences, as her papers are frequently being cited by other researchers. Similarly, her work published in prestigious journals (that are known to have high impact factor) reflects the worth of her research work. So far, she has published numerous articles with a cumulative impact factor of 130 in peer-reviewed journals.
Dr. Giovanna Ricci is affiliated with the Department of Substantive and Procedural Law Disciplines, Legal Medicine Section, University of Camerino, Italy. Dr. Giovanna Ricci has over 13 peer-reviewed articles and has authored 3 books. Her research interest includes Public Health, Forensic Science, and Criminal Law. She is also serving as the editorial board member of International Maritime Health and Clinical and Experimental Hypertension since 2016. Dr. Ricci is also involved in the review activity of the journals' PloS One, Omics, A Journal of Integrative Biology, Clinical Research, and Bioethics, Research Ethics.
Prof. Roohbakhsh got his Pharm. D. and Ph. D. degrees from Mashhad and Tehran University of Medical Sciences, respectively. Currently, working as an associate professor of pharmacology in the school of pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Dr. Roohbakhsh has been working as a university lecturer since 2006. In addition, he is the assistant editor of Iranian Journal of Basic Medical Science, which is indexed in PubMed and ISI.
Dr. Rosaria Saletti is a Senior Researcher of Organic Chemistry in University of Catania. She has participated in various national and international research programs. She has coordinated a research unit within the Research Project of National Interest and also participated for research projects in collaboration with public institutions and pharmaceutical industries overall. She is a member of the teaching staff of the PhD course in “Chemical Sciences” of the University of Catania. Dr. Rosaria Saletti is author of 70 scientific papers on international referred journals, and also of around 140 communications in scientific national and international meetings over the years.
Dr. Semwal obtained his PhD degree in Phytochemistry and Phytopharmacology from Garhwal University, India, and currently working as a senior faculty member at Uttarakhand Ayurved University, Dehradun, India. Dr. Semwal has rich experience in the field of traditional medicine, semi-synthesis of natural products, and Ayurveda. He worked in different laboratories in India and abroad, and received research grants from various international funding agencies. For the past many years, he is working in the area of diabetes mellitus and its related complications including animal and clinical trials in this area.
Dr. Marios Spanakis is a collaborative researcher with the Computational BioMedicine Laboratory (CBML) at the Institute of Computer Science of the Foundation for Research & Technology - Hellas. He holds a B.Sc. and a Ph.D. in Pharmacy from the School of Pharmacy of Aristotle University of Thessaloniki. Research interests are related mainly with novel approaches of personalized and stratified medicine, pharmacokinetics and in silico pharmacology, such as the assessment of physiologically based models for evaluation of PK/PD profiles of drugs. The expertise in pharmacology is further utilized in CBML regarding the development of innovative personalized eHealth services for achieving optimum disease management and therapy outcome. Till today, his research findings have been published in a series of peer-reviewed international journals and conferences and have gained attention from the scientific community with more than 300 citations.
Dr. Paschalis Steiropoulos obtained his Ph.D. degree (in 2007) in Medicine from Democritus University of Thrace, Alexandroupolis, Greece. Dr. Steiropoulos is currently employed as Assistant Professor, in the Department of Pulmonology, at Democritus University of Thrace. His research interests mainly lie in the subject areas/fields of Sleep Disorders and Sleep Medicine, Chronic Obstructive Pulmonary Disease, Lung Diseases, Pulmonary Medicine, Spirometry, Bronchiectasis, Respiration Disorders, etc. Dr. Steiropoulos, as an author/co-author, has published more than 90 articles in various journals, having over 1,000 total citations.
Dr. Shams Tabrez received his Ph.D degree in Biochemistry from Aligarh Muslim University, India in the year 2010. Currently, he is working as Associate Professor at KFMRC. He has vast experience in the field of clinical pharmacology. He is also having strong research interest in the field of natural compounds based therapy which has fetched him good number of publications. He has published 112 articles in the journals of international repute till date and some more are in pipeline. He has also been credited to publish a book and chapter with reputed international publishing agency at Germany (Total Citations: 1938; h-index: 25; i10-index: 60). He has successfully accomplished a number of projects funded by different funding bodies based in the Kingdom of Saudi Arabia.
Enrique Teran, M.D., Ph.D. is Professor at School of Medicine in the Universidad San Francisco de Quito. He received his MD from Central University of Ecuador and his PhD from University College London in the UK. Although he is a pharmacologist, he has been working for more than 20 years on different aspects related to the pathophysiology of preeclampsia, study of infectious diseases; he is the pioneer in the pharmacogenetic research in Ecuador. He has published more than 50 peer review papers and currently he is corresponding member both at the Ecuadorian Academy of Science and the Academy of Medicine.
Dr. Ahmet Ulugol is a Professor of Pharmacology at the School of Medicine of Trakya University in Edirne, Turkey. He has more than 30 years of experience in basic pharmacology studies. So far, Dr. Ulugol has published more than 40 peer-reviewed manuscripts in international scientific journals. His research interests include basic pain research, esp. neuropathic pain, cannabinoids and opioids. He is now a member of IASP and CCIC, honorary editor of Balkan Medical Journal, and editorial board members of Acta Scientific Pharmaceutical Sciences, SRL Drug Metabolism & Toxicology, EC Neurology, World Journal of Anesthesiologyand Remedy OA Journal - Pharmacology.
Paolo Usai-Satta (MD) is a gastroenterologist with an expertise in digestive pathophysiology. He is a clinical physician at Gastroenterology Unit of Brotzu hospital in Cagliari (Italy). His research is focused on Irritable bowel syndrome, alimentary intolerances, celiac disease and digestive motility disorders. He is member of European Society of NeuroGastroenterology and Motility and Italian Group of Digestive Motility. He is also advisor board member of Italian Association of Hospital Gastroenterology (AIGO).
Dr. Bhuvaneshwar Vaidya, Senior Research Associate at Texas Tech University Health Sciences Center, Amarillo TX- USA, has been working for more than ten years on drug discovery and novel drug delivery systems for effective delivery of bio-actives for treatment of variety of disorders. His major research areas include exploitation of novel carriers and bio-ligands for treatment of cardiovascular disorders particularly stroke, thromboembolism and pulmonary arterial hypertension, and cancer. He is widely visited researcher and presented several papers in international and national conferences. He has also been awarded for Career Award for Young Teachers by All India Council for Technical Education, Govt. of India.
Dr. V. Arul is currently an Associate Professor at the Department of Biotechnology, School of Life Sciences, Pondicherry University, Pondicherry, India. He did M.Sc. in Integrated Biology from School of Biological Sciences, Madurai Kamaraj University, Maduari in 1981. He obtained his PhD in Biology from Madurai Kamaraj University in 1989. Dr. Arul has numerous honors, awards and scientific publications to his credit.
Dr. Eman Refaat Youness, MD in Medical Biochemistry from Faculty of Medicine, Cairo University. Currently, she is a Professor in Medical Biochemistry Department at the National Research Centre, Egypt. She has published more than 150 articles, 15 books. She serves as a reviewer and an editorial board member for various journals. Dr. Youness is also a member of International Societies.
Dr. Burak Yulug is Professor of Neurology in Alanya University. He is a Stroke neurologist. After finishing his residency training in Turkey and Germany at many University Clinics, he has worked as a scientist in many Brain Research Centers in Germany and Switzerland. His main interest is Neuroregeneration and Neurodegeneration Research. Dr. Yulug has published more than 40 papers in SCI journals as the first author. He has also contributed to many international book chapters.
Dr. Ahmed A. Abd-Rabou is a researcher at the National Research Center (NRC) in Egypt. Dr. Abd-Rabou obtained his M.Sc. degree (2011) and Ph.D. degree (2015) in Biochemistry and Molecular Biology from Cairo University, Egypt (approved by Rostock University in Germany and University of Hong Kong in China). Since 2008, his projects have been focused on “Cancer Biology, Signaling, Metabolism, and Targeted Nano-Delivery” as well as “HCV Response”, yielding over 20 peer-reviewed publications. Dr. Abd-Rabou also won a competitive Post-Doctoral at INSERM, Dijon, France, under a project entitled, “Functionalization of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand on Celecoxib-Loaded Nanoparticles to Overcome Cancer Multi-Drug Resistance”.
Ana Isabel Rocha Faustino, is a master in Veterinary Medicine from University of Trás-os-Montes and Alto Douro (UTAD) and PhD in Veterinary Sciences from the same university (UTAD). Her main research interests are: the animal models of chemically-induced mammary cancer, tumoral angiogenesis, lymphangiogenesis, and ultrasonography. She participated in an investigation project funded by the Portuguese Foundation for Science and Technology. The outcomes of her work were published in several formats, she is author/coauthor of 35 papers. She has served as a reviewer in several journals (reviewer of one hundred and three manuscripts collectively). She has a rich experience in university teaching, and alsosupervised graduate and post-graduate students overall.
Sherif T.S. Hassan is a lecturer and researcher of Pharmacognosy at University of Veterinary and Pharmaceutical Sciences (UVPS), Brno, Czech Republic. Dr. Hassan has obtained his Ph.D. degree in Pharmacognosy from UVPS, Brno, Czech Republic. His main research interests are focusing on pharmacology and toxicology, molecular pharmacology of natural products, and infectious diseases. In addition to his role as a lecturer and researcher at UVPS, Dr. Hassan is a member of editorial board of international journals such as Frontiers in Pharmacology, Frontiers in Microbiology, Frontiers in Nutrition along with his role as a Guest Editor of Viruses, Marine Drugs, and International Journal of Environmental Research and Public Health. He is an active member of several international societies such as Czech Pharmaceutical Society, the American Society of Pharmacognosy, Phytochemical Society of Europe, American Society for Pharmacology and Experimental Therapeutics, and International Union of Basic and Clinical Pharmacology.
Małgorzata Kujawska graduated with an MSc. and Ph.D. with habilitation in pharmaceutical sciences at Poznan University of Medical Sciences. Dr. Kujawska completed workshops on design thinking at Stanford University and the International Summer School on Technology Transfer in Life Sciences (Technische Universität Dresden) and participated in an internship in NASA Ames Research Center at Synthetic Biology Innovation Lab. She is in the Top 1% of Reviewers for Pharmacology & Toxicology according to Publons (Clarivate). Her ongoing research interest is the implication of the Brain-Gut Axis in neurodegeneration and neuroprotection. Dr. Kujawska served as an expert in institutions financing R&D activities.
Dr. Anoop Kumar is working as Assistant Professor in Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, Lucknow-India. Earlier, he has worked as officiating Head and Associate Professor in Department of Pharmacology, Indo-Soviet Friendship College of Pharmacy (ISFCP), Moga, Punjab. He has been selected as DST INSPIRE Fellow (2012). He has also worked in Medical Affairs and Clinical Research Department of Sun Pharmaceutical Limited, Gurugram and Translational Health Science Institute (THSTI), Faridabad, India. He has authored more than 45 research and review articles and 05 book chapters in publishers of international repute (Springer, Wiley, RSC, Elsevier, Bentham publishers etc.).
Dr. Lee is an Associate Professor at the Department of Psychiatry, Inje University Haeundae Paik Hospital, College of Medicine, Inje University, Busan, South Korea. His main research interests are Psychopharmacology of patients with Schizophrenia Spectrum and Other Psychotic Disorders, especially Maintaining treatment with Antipsychotics and Dopamine Neuromodulation of Antipsychotics in First-episode and Treatment- resistant Schizophrenia and nutritive supplements for Early Psychosis.
Dr. Majid Mahdavi, is an Associate Professor of Biochemistry and Cancer Cell Biology at the University of Tabriz, Iran. He obtained his MSc and Ph.D from the Institute of Biochemistry and Biophysics, University of Tehran, Iran during 2005 to 2011. His primary focus is of research lab investigating molecular mechanisms of tumor development and progression. Dr. Majid has applied different human cancer cell lines to comprehensively understand apoptotic signal transduction pathways in order to integrate this knowledge into strategies to effectively and specifically kill cancer cells for therapeuticalpurposes. Currently, he is working on the cytotoxicity, apoptosis inducing activity and molecular docking of the different derivatives and nanoparticles in human cancer cells.
Dr. Hossein Mahmoudvand is an assistant professor of medical parasitology in the Lorestan University of Medical Sciences, Khorramabad, Iran. He received his Ph.D and MSc in Medical Parasitology and BSc in Medical Laboratory Sciences from the Kerman University of Medical Sciences, Kerman, Iran. He has published more than 50 papers; whereas his main research interest is application of herbal and synthetic drugs in the treatment of microbial diseases, epidemiology of diseases, medical parasitology and parasites & host behavior.
Professor Mukattash is a researcher in pharmaceutical care with specific interest in pediatrics, he is a professor at the Faculty of Pharmacy/ Jordan University of Science and Technology. Professor Mukattash holds a BSc in Pharmacy from the University of Jordan and a PhD in Clinical Pharmacy from Queen’s University Belfast. He has published extensively in pharmacy practice, clinical pharmacy, and pharmaceutical care and has more than 70 publications in international journals.
Dr. Nounou is highly innovative and tenacious professional pharmaceutical formulator. More than 10 years of experience in drug formulations, pharmaceutical bioconjugation, chemical synthesis, polymeric and peptidomemetic structures design, anti-cancer drug evaluation and targeted drug delivery. He has profound knowledge of physical chemistry and practical expertise in developing various formulations. He has expertise in pharmaceutical polymer chemistry, non-viral gene delivery, topical and vesicular drug delivery systems and in-vitro/ in-vivo formulations evaluation. Extensive experience in designing, characterizing and evaluating targeted drug and gene carrier systems. Known for versatility and effectiveness in stressful situations; demonstrates “big picture” vision and sensitivity to bottom-line in order to deliver high-quality projects and tasks.
Dr. Arli Aditya Parikesit is the head of the bioinformatics department at Indonesia International Institute for Life-Sciences (i3L). He finished his bachelor and master both in Chemistry, University of Indonesia. In order to pursue the degree in Bioinformatics, he accepted DAAD (German Academic Exchange Service) fellow to conduct doctorate research at Bioinformatics Group, Faculty of Informatics and Mathematics, University of Leipzig, Germany. His doctoral research is focused on the utilization of modern protein domain annotation techniques to the three domains of life. In addition, Dr. Arli is also an expert in immunoinformatics, in silico drug design, and in silico transcriptomics.
Giandomenico Roviello is research fellow of the University of Brescia, Section of pharmacology and University Center DIFF-Drug Innovation Forward Future, department of Molecular and Translational Medicine, Unit of molecular therapy and pharmacogenomic, ASST Cremona. His current research interests are genitourinary oncology, and particularly prostate cancer, gastric cancers, breast cancer and targeted anticancer therapies. Dr. Roviello has published 60 articles in peer-reviewed journals. He sits on the editorial board and is a reviewer for several oncological journals. Dr. Roviello’s society memberships include: the European Societies for Medical Oncology, the Italian Association for gastric research, Italian Association of Medical Oncology.
Ahmad Salimi is an assistant professor of toxicology in the Department of Pharmacology and Toxicology at the Ardabil University of Medical Sciences. He studied Toxicology in Ahvaz (Ahvaz Jundishapur University of Medical Sciences) and did his PhD in Tehran (Shahid Beheshti University of Medical Sciences). His research focuses on the selective toxicity new drugs on cancer cell, the interface between chemical agents and immune system, mechanistic toxicology using isolated cells and mitochondria and also cell culture. A special interest is the use of mitochondria for therapy of various diseases. He has (co-)authored more than 56 papers and 6 book chapters.
Dr. Mohamed E.E. Shams is a professor and head of the Dept. of Clinical Pharmacy and Pharmacy Practice in the Faculty of Pharmacy at University of Mansoura in Egypt. He was working as a head of the Dept. of Pharmacy Practice College of Health Sciences in Muscat, Oman between 2011-2019. Prof. Shams earned his Ph.D. from Johannes Gutenburg University of Mainz in Germany. His pharmacy experience includes practice in patient care, clinical pharmacogenetics, clinical pharmacokinetics, therapeutic drug monitoring etc. He has many papers and projects either presented or published in reputed journals. His research interest includes focusing on therapeutic drug monitoring of psychoactive and antidepressant drugs; phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry; detection of gene deletions, mutations or multiplications of metabolizing enzymes; electronic prescribing; measuring the rate of therapeutic adherence to medications, innovative medicines, technologies and approaches for improving patients’ healthcare.
Abhisheak Sharma is a trained analytical scientist, pharmacokineticist, and pharmacist whose research focuses on the in vivo and in vitro preclinical pharmacokinetic studies of new chemical entities and natural products. He earned his Ph.D. in pharmacokinetics & metabolism from CSIR-Central Drug Research Institute, Lucknow, India. Dr. Sharma did his post-doctoral research at the University of Mississippi (2015-2017) and University of Florida (2017-2019). Currently, he is working as a Research Assistant Professor at the Department of Pharmaceutics, University of Florida, Gainesville. His research interests include: pharmacokinetics, drug development, drug-drug interaction and pharmacokinetic modeling and simulation.
Dr. Marko Stojanović graduated and completed his Master’s and Ph.D. studies in medical science, at the Faculty of Medicine, University of Belgrade, Serbia. Previously, his main fields of interest were related to the animal models of different cardiovascular pathology, and investigation of different substances that can be used for treatment of cardiovascular diseases. Currently, he is interested in clinical pharmacology (CP) work of ICU units and the CP related problems of geriatric population. Dr. Stojanović participated in two investigation projects of Serbian Ministry of Education and Science, and in one FP-7 project financed by EU.
Dr. Pengyuan Sun is currently an Associate Professor at the Department of Pharmacology, College of Pharmacy, Dalian Medical University. He did M.M. in Pharmaceutics from the Department of Pharmaceutics, College of Pharmacy, Yanbian University, Yanji, China in 2006. Later, he did PhD in Clinical Pharmacology from the Department of Clinical Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. Dr. Sun’s research interests are Cardiovascular pharmacology and Transporter mediated drug-drug interaction and its molecular pharmacokinetics effects.
Dr. Bogdan Ionel Tamba is Research Professor at the Center for Advanced Research and Development in Experimental Medicine from “Grigore T. Popa” University of Medicine and Pharmacy from Iasi, Romania and Associate Professor at the Faculty of Medicine of the same university. He holds a Medical Doctor degree and a PhD degree in Pharmacology awarded by “Grigore T. Popa” University of Medicine and Pharmacy from Iasi, Romania in 2004 and 2010 respectively. The main research areas in which he is conducting research are fundamental and applicative research, pharmacological action, preclinical and pharmacological therapeutic research, identification of integrative molecular and physiological pharmacological mechanisms of medicinal substances, pharmacokinetics and pharmacodynamics on drug substances, investigations of therapeutic agents in the body (absorption, distribution, metabolism and elimination) and interactions and effects on living tissues, in vitro and in vivo studies.
Ewoud-Jan van Hoogdalem, PharmD PhD, is Vice President Global Scientific Affairs in Early Development Services of PRA Health Sciences. He has more than 25 years of drug development experience with small biotech and large pharma companies including JNJ and Yamanouchi (now Astellas). He is board-certified clinical pharmacologist and licensed pharmacist with a PhD from Leiden University. He is member of various professional organizations, co-organizer of various scientific conferences, and is first author/co-author in over 30 publications in peer-reviewed journals or book chapters